Imaging contrast enhancement

**Imaging contrast enhancement** is not a specific molecule, receptor, or therapeutic target. Instead, it refers to a diagnostic technique used in medical imaging—such as CT scans, MRI, and ultrasound—where special substances called **contrast agents** are administered to the patient to improve the visibility of blood vessels, tissues, and organs on images. These substances can be iodine-based for CT scans, gadolinium-based for MRIs, or microbubble formulations for ultrasounds. The primary purpose is to increase the difference in appearance between adjacent structures or between normal and abnormal tissue so that pathologies such as tumors or vascular abnormalities can be more easily detected and characterized[1][2][3][5]. Contrast enhancement is widely used across many fields including oncology (to visualize tumors), cardiology (to assess blood flow), neurology (to detect brain lesions), and gastroenterology. It does not refer to a single molecular entity but rather an entire class of diagnostic techniques utilizing various chemical compounds as enhancers. Because "imaging contrast enhancement" describes a process/technique rather than an individual molecular target like a receptor or enzyme—and because it encompasses multiple unrelated chemical entities—it should not be considered a canonical drug target. Therefore: > **This entry is incorrect as a drug/molecular target; it refers instead to an imaging technique using various exogenous compounds ("contrast media") rather than any single molecule/receptor/protein that could serve as the focus for targeted therapy development.[1][2][5]** If you need information about specific molecules used as imaging targets—such as particular receptors imaged by radiotracers—or about individual classes of clinically relevant contrast media themselves (e.g., "Gadolinium(III) chelate"), those would each have their own structured entries.

Other names

Contrast-enhanced imagingContrast enhancementContrast-enhanced ultrasound (CEUS)Contrast-enhanced scan

Increase visibility of internal structures by altering imaging signal properties after administration of a contrast agent[1][2][3]